A book arrived in May 2025 that many in the public health world have been waiting for. Marketing Pleasure: How Addictive Drug Industries Tell Big Lies to Make Big Profits by Sue Rusche is not a polemic. It is a meticulously researched account of how powerful commercial forces spent decades deceiving the public, targeting children, and quietly profiting while families paid the price in lives.

Have you ever wondered how industries built on selling harmful substances stay not just legal but celebrated? This book answers that with uncomfortable clarity.

A Crisis Driven by Addictive Drug Industries

The numbers alone should stop us in our tracks. Every year in the United States, tobacco claims approximately 480,000 lives. Alcohol kills around 178,000. Opioids take more than 100,000. That is well over three quarters of a million deaths annually. Each death ties back to products that addictive drug industries have aggressively marketed, even as they knew the full extent of the harm.

Yet the advertising continues. The lobbying continues. And the lies continue too.

What Addictive Drug Industries Actually Do

Sue Rusche spent 46 years leading National Families in Action. She knows up close how addictive drug industries operate, and she does not shy away from naming their methods.

The tobacco industry essentially wrote the playbook. Other sectors borrowed, refined, and redeployed its tactics with remarkable consistency. Those tactics include:

Denying the science. For decades, tobacco executives stood before Congress and swore that nicotine was not addictive and that cigarettes did not cause cancer. Internal documents, later released through litigation, told an entirely different story.

Targeting young people. Research shows that early substance use sharply raises the risk of dependency. Drug industry manipulation aims squarely at teenagers and young adults through cartoon mascots, flavoured products, and social media campaigns that never mention risk.

Increasing addictive properties. Rather than making products less harmful, some industries engineer them to be more addictive. They lock in consumers before those consumers fully grasp what they are taking on.

Flooding markets with advertising. Addictive drug industries spend billions crafting stories of pleasure, freedom, and sophistication around substances that, for many users, become sources of compulsion and suffering.

Drug Industry Manipulation Behind Cannabis Legalisation

Marketing Pleasure is particularly timely in how it examines drug industry manipulation in the push to legalise cannabis. Rusche traces how three billionaires, each with significant financial stakes in a legal marijuana market, worked to shift public perception and policy. They lobbied first for medical use, then recreational.

The parallels with tobacco are not coincidental. They are deliberate. Professor Jonathan P. Caulkins of Carnegie Mellon University, who co-authored Marijuana Legalization: What Everyone Needs to Know, says the book tells the story of how corporations lied about drug dangers while everyday people fought back.

Research on cannabis harm keeps growing. Studies now link heavy use to adolescent brain development issues and a higher risk of psychosis. Yet addictive drug industries drown out that evidence with marketing budgets that dwarf what public health communicators can spend. A 2021 study in the journal Addiction found that cannabis industry advertising in states with legal sales outpaced health messaging by a ratio of more than 10 to 1.

A Movement That Proved Change Is Possible

One of the most hopeful sections of this book tells the story of the National Parent Movement. In the late 1970s, as youth cannabis use reached then-historic highs, ordinary parents organised. They shared information, pushed for policy change, and refused to accept that teenage drug use was inevitable.

Youth marijuana use fell dramatically over 14 years. Not because the industry became more responsible. Because communities decided enough was enough.

That story gets lost in the noise of culture wars and commercial lobbying. Rusche brings it back, reminding us that drug industry manipulation is not unstoppable. Informed communities have beaten it before.

Why Addictive Drug Industries Cannot Be Ignored Now

Kevin Sabet, PhD, founder, president, and CEO of the Foundation for Drug Policy Solutions and Smart Approaches to Marijuana, calls Rusche “a national treasure.” He says you cannot claim to understand drug policy without reading this book. That is not hyperbole.

Several countries and many US states are deciding whether cannabis joins tobacco and alcohol as a fully commercialised legal drug. The question Rusche poses is simple and devastating: knowing what we know about how addictive drug industries operate, and knowing the lies told before, do we want to hand another substance to the same commercial machinery?

The death tolls from tobacco, alcohol, and opioids did not appear overnight. Industries built them product by product, campaign by campaign, over decades. All three were once considered new and relatively harmless. Their advocates argued that benefits outweighed risks, that regulation was unnecessary, that science was unsettled.

Sound familiar?

Reading Marketing Pleasure as a Call to Action

Sue Rusche lost nearly everyone in her family to nicotine-related illness. That personal history shapes this book without overwhelming it. She has produced less a memoir than a strategic guide to recognising the tactics of addictive drug industries before they take root again.

Susan Kendall Newman, former executive director of the Scott Newman Foundation, describes Rusche as bringing “Southern charm and a pit bull’s tenacity” to her work. That combination shows on every page. This is not a book that despairs. It insists we can do better, as long as we understand how we got here.

Marketing Pleasure is available now in hardcover. Anyone who wants to understand the mechanics of drug industry manipulation and what communities can do about it should read this book.

Source: amazon